Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Multifocal Signal Modulation Therapy by Celecoxib: A Strategy for Managing Castration-Resistant Prostate Cancer.

Benelli R, Barboro P, Costa D, Astigiano S, Barbieri O, Capaia M, Poggi A, Ferrari N.

Int J Mol Sci. 2019 Dec 3;20(23). pii: E6091. doi: 10.3390/ijms20236091.

2.

Role of Circulating Tumor Cells (CTC), Androgen Receptor Full Length (AR-FL) and Androgen Receptor Splice Variant 7 (AR-V7) in a Prospective Cohort of Castration-Resistant Metastatic Prostate Cancer Patients.

Cattrini C, Rubagotti A, Zinoli L, Cerbone L, Zanardi E, Capaia M, Barboro P, Boccardo F.

Cancers (Basel). 2019 Sep 13;11(9). pii: E1365. doi: 10.3390/cancers11091365.

3.

A hnRNP K⁻AR-Related Signature Reflects Progression toward Castration-Resistant Prostate Cancer.

Capaia M, Granata I, Guarracino M, Petretto A, Inglese E, Cattrini C, Ferrari N, Boccardo F, Barboro P.

Int J Mol Sci. 2018 Jun 30;19(7). pii: E1920. doi: 10.3390/ijms19071920.

4.

Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer.

Ferrari N, Granata I, Capaia M, Piccirillo M, Guarracino MR, Venè R, Brizzolara A, Petretto A, Inglese E, Morini M, Astigiano S, Amaro AA, Boccardo F, Balbi C, Barboro P.

Cell Commun Signal. 2017 Dec 8;15(1):51. doi: 10.1186/s12964-017-0206-x.

5.

Interleukin 21 Controls mRNA and MicroRNA Expression in CD40-Activated Chronic Lymphocytic Leukemia Cells.

De Cecco L, Capaia M, Zupo S, Cutrona G, Matis S, Brizzolara A, Orengo AM, Croce M, Marchesi E, Ferrarini M, Canevari S, Ferrini S.

PLoS One. 2015 Aug 25;10(8):e0134706. doi: 10.1371/journal.pone.0134706. eCollection 2015.

6.

Expression of nuclear matrix proteins binding matrix attachment regions in prostate cancer. PARP-1: New player in tumor progression.

Barboro P, Ferrari N, Capaia M, Petretto A, Salvi S, Boccardo S, Balbi C.

Int J Cancer. 2015 Oct 1;137(7):1574-86. doi: 10.1002/ijc.29531. Epub 2015 Apr 6.

7.

Heterogeneous expression and function of IL-21R and susceptibility to IL-21-mediated apoptosis in follicular lymphoma cells.

de Totero D, Capaia M, Fabbi M, Croce M, Meazza R, Cutrona G, Zupo S, Loiacono F, Truini M, Ferrarini M, Ferrini S.

Exp Hematol. 2010 May;38(5):373-83. doi: 10.1016/j.exphem.2010.02.008. Epub 2010 Mar 1.

PMID:
20193734
8.

The opposite effects of IL-15 and IL-21 on CLL B cells correlate with differential activation of the JAK/STAT and ERK1/2 pathways.

de Totero D, Meazza R, Capaia M, Fabbi M, Azzarone B, Balleari E, Gobbi M, Cutrona G, Ferrarini M, Ferrini S.

Blood. 2008 Jan 15;111(2):517-24. Epub 2007 Oct 15.

PMID:
17938255
9.

Interleukin-21 receptor (IL-21R) is up-regulated by CD40 triggering and mediates proapoptotic signals in chronic lymphocytic leukemia B cells.

de Totero D, Meazza R, Zupo S, Cutrona G, Matis S, Colombo M, Balleari E, Pierri I, Fabbi M, Capaia M, Azzarone B, Gobbi M, Ferrarini M, Ferrini S.

Blood. 2006 May 1;107(9):3708-15. Epub 2006 Jan 3.

PMID:
16391014

Supplemental Content

Loading ...
Support Center